D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESGR
3126
DELISTED
Enstar Group
ESGR
| $339K | ﹤0.01% |
1,951
-3,461
| -64% | -$601K |
|
3127
Marcus Corp
MCS
$732M
| $339K | ﹤0.01% |
8,476
-8,460
| -50% | -$350K |
|
3128
PC Connection
CNXN
$2.05B
| $337K | ﹤0.01% |
+9,196
| New | +$331K |
|
|
BID
3129
CALL
DELISTED
Sotheby's
BID
| $336K | ﹤0.01% |
8,900
| – | – |
|
3130
Hooker Furnishings Corp
HOFT
$148M
| $335K | ﹤0.01% |
11,609
-2,086
| -15% | -$61.3K |
|
3131
REX American Resources
REX
$1.46B
| $335K | ﹤0.01% |
24,912
-1,416
| -5% | -$17.9K |
|
|
EGIO
3132
DELISTED
Edgio, Inc. Common Stock
EGIO
| $335K | ﹤0.01% |
2,590
-689
| -21% | -$80K |
|
3133
Community Trust Bancorp
CTBI
$1.38B
| $334K | ﹤0.01% |
8,126
+2,684
| +49% | +$111K |
|
|
WPG
3134
DELISTED
Washington Prime Group Inc.
WPG
| $334K | ﹤0.01% |
6,568
-800
| -11% | -$39.2K |
|
|
HUYA
3135
Huya Inc
HUYA
$542M
| $332K | ﹤0.01% |
+11,816
| New | +$264K |
|
3136
Microchip Technology
MCHP
$42.8B
| $332K | ﹤0.01% |
8,000
-10,284
| -56% | -$426K |
|
3137
Royal Gold
RGLD
$17.1B
| $332K | ﹤0.01% |
3,652
-62,183
| -94% | -$5.43M |
|
3138
Rogers Corp
ROG
$2.33B
| $332K | ﹤0.01% |
2,087
-995
| -32% | -$134K |
|
3139
Rayonier Advanced Materials
RYAM
$565M
| $332K | ﹤0.01% |
24,487
+470
| +2% | +$6.37K |
|
|
DAY
3140
DELISTED
Dayforce
DAY
| $332K | ﹤0.01% |
+6,463
| New | +$286K |
|
|
NLSN
3141
DELISTED
Nielsen Holdings plc
NLSN
| $332K | ﹤0.01% |
14,006
-76,047
| -84% | -$1.97M |
|
|
BRSL
3142
Brightstar Lottery PLC
BRSL
$1.91B
| $331K | ﹤0.01% |
25,458
-86,383
| -77% | -$1.33M |
|
3143
Sierra Bancorp
BSRR
$548M
| $330K | ﹤0.01% |
13,578
-1,046
| -7% | -$27.1K |
|
3144
CALL
Itaú Unibanco
ITUB
$91.3B
| $330K | ﹤0.01% |
51,537
| – | – |
|
3145
Veritone
VERI
$96.7M
| $329K | ﹤0.01% |
+63,301
| New | +$353K |
|
3146
CALL
CACI
CACI
$10.8B
| $328K | ﹤0.01% |
+1,800
| New | +$307K |
|
|
COR
3147
DELISTED
Coresite Realty Corporation
COR
| $327K | ﹤0.01% |
+3,054
| New | +$303K |
|
3148
PUT
Abercrombie & Fitch
ANF
$4.17B
| $326K | ﹤0.01% |
11,900
-41,500
| -78% | -$931K |
|
|
SRNE
3149
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $324K | ﹤0.01% |
68,126
-825,874
| -92% | -$2.17M |
|
|
CARB
3150
DELISTED
Carbonite Inc
CARB
| $323K | ﹤0.01% |
13,025
-20,179
| -61% | -$519K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.